After in vitro tests indicated that boric acid is fungistatic against Candida albicans, it was used to treat vulvovaginal candidiasis, with symptomatic relief in all 40 patients. None of the tested patients had detectable levels of boric acid in the seurm. Thirty-eight of the 40 patients had no recurrence of symptoms 30 days after therapy. Boric acid therapy for vulvovaginal candidiasis was found to be safe, effective, and inexpensive.
© 1974 The American College of Obstetricians and Gynecologists